Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$969.6K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 20 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 113 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured
The 37 most recent Form 4 transactions.
| Aug 14 | ASND | Ascendis Pharma A/S | PBUY | 1,100 | $245.85 | $270.4K | +122.2% | Open the original filing on SEC.gov |
| Jul 15 | KROS | Keros Therapeutics, Inc. | PBUY◷ | 1,000 | $10.61 | $10.6K | +5.7% | Open the original filing on SEC.gov |
| Jun 15 | KROS | Keros Therapeutics, Inc. | PBUY◷ | 1,000 | $10.19 | $10.2K | +6.0% | Open the original filing on SEC.gov |
| Jun 10 | IMNM | Immunome Inc. | AGRANT◆ | 9,897 | — | — | — | Open the original filing on SEC.gov |
| Jun 8 | INCY | Incyte Corp | AGRANT◆ | 6,111 | — | — | — | Open the original filing on SEC.gov |
| Jun 8 | INCY | Incyte Corp | AGRANT | 1,642 | — | — | +7.2% | Open the original filing on SEC.gov |
| Jun 5 | IMNM | Immunome Inc. | PBUY | 1,000 | $19.27 | $19.3K | +2.4% | Open the original filing on SEC.gov |
| Jun 5 | IMNM | Immunome Inc. | PBUY | 3,500 | $19.46 | $68.1K | +9.0% | Open the original filing on SEC.gov |
| Jun 5 | IMNM | Immunome Inc. | PBUY | 6,000 | $19.48 | $116.9K | +18.2% | Open the original filing on SEC.gov |
| Jun 5 | IMNM | Immunome Inc. | SSELL | 10,000 | $19.41 | $194.1K | -23.3% | Open the original filing on SEC.gov |
| Jun 5 | IMNM | Immunome Inc. | SSELL | 500 | $19.44 | $9.7K | -1.1% | Open the original filing on SEC.gov |
| Jun 3 | KROS | Keros Therapeutics, Inc. | AGRANT◆ | 7,433 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | KROS | Keros Therapeutics, Inc. | AGRANT | 7,142 | — | — | +75.6% | Open the original filing on SEC.gov |
| May 29 | ASND | Ascendis Pharma A/S | PBUY | 100 | $223.50 | $22.4K | +12.5% | Open the original filing on SEC.gov |
| May 29 | ASND | Ascendis Pharma A/S | PBUY | 200 | $222.30 | $44.5K | +33.3% | Open the original filing on SEC.gov |
| May 29 | ASND | Ascendis Pharma A/S | PBUY | 200 | $223.76 | $44.8K | +50.0% | Open the original filing on SEC.gov |
| May 26 | ASND | Ascendis Pharma A/S | PBUY | 200 | $239.37 | $47.9K | +100.0% | Open the original filing on SEC.gov |
| May 26 | ASND | Ascendis Pharma A/S | PBUY | 200 | $236.24 | $47.2K | — | Open the original filing on SEC.gov |
| May 26 | INCY | Incyte Corp | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| May 26 | INCY | Incyte Corp | FTAX◷ | 13,059 | $97.10 | $1.3M | -36.4% | Open the original filing on SEC.gov |
| May 26 | INCY | Incyte Corp | MEXER◷ | 15,000 | $84.53 | $1.3M | +72.0% | Open the original filing on SEC.gov |
| May 15 | KROS | Keros Therapeutics, Inc. | PBUY◷ | 1,000 | $10.58 | $10.6K | +11.8% | Open the original filing on SEC.gov |
| May 15 | IMNM | Immunome Inc. | PBUY | 5,000 | $20.70 | $103.5K | +13.0% | Open the original filing on SEC.gov |
| Apr 15 | KROS | Keros Therapeutics, Inc. | PBUY◷ | 1,000 | $11.70 | $11.7K | +13.4% | Open the original filing on SEC.gov |
| Apr 14 | ASND | Ascendis Pharma A/S | AGRANT◆ | 9,160 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | ASND | Ascendis Pharma A/S | DTOISS◆ | 9,160 | — | — | — | Open the original filing on SEC.gov |
| Mar 11 | IMNM | Immunome Inc. | PBUY | 1,000 | $21.55 | $21.6K | +2.7% | Open the original filing on SEC.gov |
| Mar 10 | IMNM | Immunome Inc. | PBUY | 1,000 | $22.12 | $22.1K | +2.8% | Open the original filing on SEC.gov |
| Mar 9 | KROS | Keros Therapeutics, Inc. | PBUY◷ | 2,000 | $11.21 | $22.4K | +36.7% | Open the original filing on SEC.gov |
| Jun 10, 2025 | INCY | Incyte Corp | AGRANT◆ | 9,216 | — | — | — | Open the original filing on SEC.gov |
| Jun 10, 2025 | INCY | Incyte Corp | AGRANT | 2,518 | — | — | +13.7% | Open the original filing on SEC.gov |
| Jun 10, 2025 | IMNM | Immunome Inc. | AGRANT◆ | 18,864 | — | — | — | Open the original filing on SEC.gov |
| Jun 4, 2025 | KROS | Keros Therapeutics, Inc. | AGRANT◆ | 10,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 4, 2025 | KROS | Keros Therapeutics, Inc. | AGRANT | 5,250 | — | — | +2,625% | Open the original filing on SEC.gov |
| Jun 3, 2025 | IMNM | Immunome Inc. | PBUY | 5,000 | $9.38 | $46.9K | +15.9% | Open the original filing on SEC.gov |